Aptechnaya Set' 36,6 PAO AAQS
The The AAQS of Aptechnaya Set' 36,6 PAO (APTK.ME) as of Nov 20, 2026 is 5. In the previous year, The AAQS was 5.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
5
YoY
0.00%
Last updated:
Aptechnaya Set' 36,6 PAO has a current AAQS of 5.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Aptechnaya Set' 36,6 PAO in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Aptechnaya Set' 36,6 PAO in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Aptechnaya Set' 36,6 PAO AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
5.00 RUB
Jan 1, 2019
5.00 RUB
Jan 1, 2020
5.00 RUB
Jan 1, 2021
5.00 RUB
Jan 1, 2022
5.00 RUB
Jan 1, 2023
5.00 RUB
Jan 1, 2024
5.00 RUB
Jan 1, 2025
5.00 RUB
| YEAR | AAQS | YoY |
|---|---|---|
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | 0.00% | |
| 5 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Aptechnaya Set' 36,6 PAO Stock analysis
What does Aptechnaya Set' 36,6 PAO do? The Aptechnaya Set' 36.6 PAO is the largest pharmacy and retail network in Russia. The company was founded in 1998 and since then has had an impressive growth history. The business model of Aptechnaya Set' 36.6 PAO is focused on offering a comprehensive range of medical products as well as a wide selection of toiletries under one roof. The company operates over 2,800 pharmacies in all regions of Russia and is a significant player in the retail business. The various divisions of Aptechnaya Set' 36.6 PAO include both high-quality medicines as well as cosmetics and hygiene products. Customers can find everything they need here, from prescription drugs to over-the-counter medications, vitamins, and supplements. The products offered in the pharmacies of Aptechnaya Set' 36.6 PAO also include household goods and groceries sold in modern market formats. The company has also diversified its product lineup with the introduction of private labels. The brand 36.6 is now one of the most well-known brands in Russia, offering a wealth of high-quality products such as cosmetics, household, and hygiene products. The development of Aptechnaya Set' 36.6 PAO is closely linked to the development of the Russian healthcare system and consumer habits. The company has actively adapted to the changes and adjusted its strategy to meet the needs of consumers. For example, the online presence has been greatly expanded, allowing customers to conveniently shop from home at any time and place. In addition to selling products, Aptechnaya Set' 36.6 PAO has also played an important social role. The company has launched and supported various programs to help society and particularly underprivileged populations. Extensive health programs are offered, targeting both older people and children. Aptechnaya Set' 36.6 PAO is an impressive example of a successful business strategy based on customer satisfaction and service orientation. The company has made significant investments in recent years to further expand its presence in Russia and tackle the challenges of the changing healthcare market. Aptechnaya Set' 36,6 PAO is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Aptechnaya Set' 36,6 PAO stock
The AAQS of Aptechnaya Set' 36,6 PAO is 5 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Aptechnaya Set' 36,6 PAO since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Aptechnaya Set' 36,6 PAO
All Key Metrics — Aptechnaya Set' 36,6 PAO
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth